4P THERAPEUTICS

4p-therapeutics-logo

4P Therapeutics is a private company focused on the research and development of novel drug delivery technologies and therapeutics. 4P develops products that meet the needs of patients, physicians and payers. The company has capabilities for developing pharmaceutical products ranging from pre-clinical testing to clinical manufacturing and early stage clinical development (Phase I/II). A key company focus and area of expertise is in the development of transdermal products for currently injected compounds, including proteins, peptides, macromolecules and biologics. Transdermal delivery of commercially available drugs or biologics that are typically delivered via injection has the potential to improve safety, efficacy and therapeutic outcomes associated with these treatments.

#People #Website #More

4P THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Medical Device Pharmaceutical

Founded:
2011-01-01

Address:
Peachtree City, Georgia, United States

Country:
United States

Website Url:
http://www.4ptherapeutics.com

Total Employee:
11+

Status:
Active

Contact:
(770) 263-1900

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt WordPress Google Universal Analytics Wordpress Plugins


Founder


not_available_image

Steven P. Damon

Official Site Inspections

http://www.4ptherapeutics.com

  • Host name: static.61.63.13.49.clients.your-server.de
  • IP address: 49.13.63.61
  • Location: Germany
  • Latitude: 51.2993
  • Longitude: 9.491
  • Timezone: Europe/Berlin

Loading ...

More informations about "4P Therapeutics"

4P Therapeutics - Crunchbase Company Profile

4P Therapeutics is a private company focused on the research and development of novel drug delivery technologies and therapeutics.See details»

4P Therapeutics Company Profile | Management and Employees …

4P Therapeutics Profile and History 4P Therapeutics is a private company focused on the research and development of novel drug delivery technologies and novel drug delivery based …See details»

4P Therapeutics LLC Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for 4P Therapeutics LLC of Peachtree Corners, GA. Get the latest business insights from Dun & …See details»

4P Therapeutics - Overview, News & Similar companies

View 4P Therapeutics (www.4ptherapeutics.com) location in Georgia, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»

4P Therapeutics - Craft

4P Therapeutics is a company developing pharmaceutical products from pre-clinical testing to clinical manufacturing and early-stage clinical development (Phase I/II). It focuses on …See details»

Management – 4P Therapeutics

Alan Smith, Ph.D. HEAD OF 4P THERAPUTICS, AND HEAD OF CLINICAL, REGULATORY, QUALITY, & OPERATIONS AT NUTRIBAND INCSee details»

4P Therapeutics LLC - Drug pipelines, Patents, Clinical trials

May 8, 2025 Explore 4P Therapeutics LLC with its drug pipeline, therapeutic area, technology platform, 4 news.See details»

About – 4P Therapeutics

4P Therapeutics is a wholly owned subsidiary of Nutriband Inc, focused on the research and development of novel drug delivery technologies and therapeutics. 4P develops products that …See details»

4P Therapeutics: Contact Details and Business Profile

4P Therapeutics is a Biotechnology, Manufacturing General, and Manufacturing company_reader located in Norcross, Georgia with $4 million in revenue and 0 employees. Find top employees, …See details»

4p | Drug Delivery Experts

4P has world-leading experience in the novel transdermal area. This experience is leveraged to determine the appropriate transdermal technology for a particular drug candidate. 4P selects a …See details»

4P Therapeutics - VentureRadar

"4P Therapeutics is a clinical subsidiary of Nutriband Inc. (NTRB) focused on the research and development of novel drug delivery technologies and therapeutics. The company has …See details»

Nutriband Inc. Acquires 4P Therapeutics Inc.

Nutriband has acquired 100% interest in 4P Therapeutics for a total of $1,900,000 payable in both company stock and cash. 4P Therapeutics will receive 250,000 shares of common stock and a …See details»

Nutriband Subsidiary, 4P Therapeutics LLC, Conducts Phase 1b …

ORLANDO, FL / ACCESSWIRE / October 26, 2022 / Nutriband Inc. (the "Company") (NASDAQ:NTRB) (NASDAQ:NTRBW) today announced that its subsidiary, 4P Therapeutics …See details»

Contact – 4P Therapeutics

Contact 4P Therapeutics today to find out about our Partnership options 4P specializes in accelerating products from concept to proof-of-concept, by moving quickly from the …See details»

Dr. Alan Smith | Nutriband

At Altea, he led major research and development programs with pharmaceutical companies such as Eli Lilly, Amylin, Hospira, Elan, and Novartis. He joined Altea as one of the first employees …See details»

4P Therapeutics - VentureRadar

4P Therapeutics is a clinical subsidiary of Nutriband Inc. (NTRB) focused on the research and development of novel drug delivery technologies and therapeutics. The company has …See details»

4P Therapeutics 2025 Company Profile: Valuation, Investors

Information on acquisition, funding, investors, and executives for 4P Therapeutics. Use the PitchBook Platform to explore the full profile.See details»

Clinical Research – 4P Therapeutics

4P Therapeutics performs clinical research in compliance with FDA Good Clinical Practices (GCP) and ICH guidelines. Clinical Research supports development of drug delivery products from …See details»

Five Trends Reshaping Pharmaceutical Manufacturing Partnerships ...

Apr 23, 2025 The pharmaceutical manufacturing landscape is undergoing a profound shift, with contract development and manufacturing organizations (CDMOs) evolving from simple …See details»

Nutriband COO Alan Smith Ph.D. Selected for FDA Center for …

ORLANDO, FL / ACCESSWIRE / March 2, 2023 / Nutriband Inc. (the "Company") (NASDAQ:NTRB)(NASDAQ:NTRBW) today announced that Alan Smith, Ph.D., Chief …See details»